Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Piper Sandler

Piper Sandler initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note issued to investors on Monday, MarketBeat reports. The brokerage set an “overweight” rating and a $27.00 price target on the stock. Piper Sandler’s target price indicates a potential upside of 9.85% from the company’s previous close.

Several other analysts have also commented on the stock. The Goldman Sachs Group assumed coverage on shares of Kestra Medical Technologies in a research note on Monday. They set a “neutral” rating and a $24.00 target price for the company. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research report on Monday. They set a “buy” rating and a $28.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Kestra Medical Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Stock Down 1.4 %

Shares of NASDAQ KMTS opened at $24.58 on Monday. Kestra Medical Technologies has a twelve month low of $20.00 and a twelve month high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.